NeurologyLive® Friday 5 — May 5, 2023

Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 5, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Early Identification and Personalized Care in Spinal Muscular Atrophy: Insights From Brazil

In this feature from our April print edition, experts review the state of SMA diagnosis and medications, highlighting factors that guide treatment selection in North America and South America.

Early Identification and Personalized Care in Spinal Muscular Atrophy: Insights From Brazil

2: Peer Exchange: Generic Disease-Modifying Therapies (DMTs) in RRMS

In episode 3 of this Peer Exchange series on "The Shifting Treatment Landscape of RRMS", expert neurologists review the availability of generic disease-modifying therapies [DMTs] and the effectiveness of reduced cost to the patient with RRMS.

Generic Disease-Modifying Therapies (DMTs) in RRMS

3: NeuroVoices: John Hey, PhD, on ALZ-801’s Impact on Alzheimer Biomarkers, P-Tau181

In the latest edition of our in-depth Q&A series, the chief scientific officer at Alzheon discussed new, positive 12-month findings on ALZ-801, an investigational agent in development for patients with early-stage Alzheimer disease.

NeuroVoices: John Hey, PhD, on ALZ-801’s Impact on Alzheimer Biomarkers, P-Tau181

4: AAN Annual Meeting 2023: Top Expert Interviews

A group of experts in the care of patients with neurological conditions—Ali Jannati, MD, PhD; Madhav R. Thambisetty, MD, PhD; Daniel Ontaneda, MD, PhD; Peter J. Goadsby, MD, PhD, DSc; Andrew Russman, DO—shared their perspectives on hot topics of treatment and management in neurology from the 2023 American Academy of Neurology Annual Meeting.

AAN Annual Meeting 2023: Top Expert Interviews

5: Neurology News Network: Shared Decision-Making In Parkinson Disease Care

In this episode of Neurology News Network, Stuart H. Isaacson, MD, FAAN, an expert in the management of Parkinson disease, discusses the key role that shared decision-making plays in the modern treatment paradigm.

Shared Decision-Making In Parkinson Disease Care
Related Videos
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
Video 5 - "Contribution of Multiple Pathways to the Development of Alzheimer’s Disease"
Michael Levy, MD, PhD
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.